Prevalence of myelomeningocele and patient characteristics in Rio Grande do Norte State, Brazil
DOI:
https://doi.org/10.24220/2318-0897v21n1/6a1872Keywords:
Risk factors, Meningomyelocele, PrevalenceAbstract
Objective
This study aimed to idenüfy the prevalence of children with myelomeningocele and describe their characteristics.
Methods
A questionnaire was used for collecting the following data from children with myelomeningocele who visíted the Hospital Infantil Varela Santiago in Rio Grande do Norte between 2004 and 2005: sex, associated congenital malformation,
mother’s education level. household income. home’s water source, Social
Assistance, prenatal diagnosis of myelomeningocele and family history of the disease
Results
Myelomeningocele prevalences in 2004 and 2005 were 6:10,000 and 2:10,000 live births, respectively. Most (82.6%) patients also had hydrocephalus, 59.1%, were male, 22.7% had been díagnosed before birth by ultrasound, 13.6%, had a
family history of myelomeningocele, 4.3% had Social Assistance, 56.5% had a household income equal to or below one minimum wage, 91,0% of the households had piped water. 50. OC)/, of the households consumed homemade cassava flour, 47.8% of the chIldren's mothers had less than 4 years of formal education, aII mothers had attended prenatal care, 40.9Q/, of the mothers started
prenatal care on the second trimester of pregnancy, and 13.6% of the mothers did not take vitamin supplements during pregnancy,
Conclusion
The study draws attention to the fact that some mothers only began prenatal care on the second trimester of pregnancy. and worse, the disease was often not detected by ultrasound. The study shows that education actions on woman's
health and better quality diagnostic services are necessary.
Downloads
References
Stoll C, Dott B, Alembik Y, Roth MP. Associated malformations among infants with neural tube defects. Am J Med Genet A. 2011; 155A(3):565-8.
Juranek J, Salman MS. Anomalous development of brain structure and function in spina bifida myelomeningocele. Dev Disabil Res Rev. 2010; 16(1):23-30.
Brand MC. Examining the newborn with an open spinal dysraphism. Adv Neonatal Care. 2006; 6(4):181-96.
Grillo E, Silva RJM. Defeitos do tubo neural e hidrocefalia congênita: por que conhecer suas prevalências? J Pediatr. 2003; 79(2):105-6.
Aguiar MJB, Campos ÂS, Aguiar RALP, Lana AMA, Magalhães RL, Babeto LT. Defeitos de fechamento do tubo neural e fatores associados em recém-nascidos vivos e natimortos. J Pediatr. 2003; 79(2):129-34.
Pacheco SS, Souza AId, Vidal SdA, Guerra GVdQL, Batista Filho M, Baptista EVP, et al. Prevalência dos defeitos de fechamento do tubo neural em recém-nascidos do Centro de Atenção à Mulher do Instituto Materno Infantil Prof. Fernando Figueira, IMIP: 2000-2004. Rev Bra Saúde Mater Infant. 2006; 6(Suppl 1):s35-s42.
De Marco P, Merello E, Mascelli S, Capra V. Current perspectives on the genetic causes of neural tube defects. Neurogenetics. 2006; 7(4):201-21.
Bassuk AG, Kibar Z. Genetic basis of neural tube defects. Semin Pediatr Neurol. 2009; 16(3):101-10.
Liao Y, Wang J, Li X, Guo Y, Zheng X. Identifying environmental risk factors for human neural tube defects before and after folic acid supplementation. BMC Public Health. 2009; 9:391.
Ulsenheimer MMM, Antoniuk SA, Santos LHC, Ceccatto MP, Silveira AE, Ruiz AP, et al.
Myelomeningocele: A Brazilian University Hospital experience. Arq Neuro-Psiquiatr. 2004; 62(4):963-8.
Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto). 2006; 46(2):55-67.
Kondo A, Kamihira O, Ozawa H. Neural tube defects: prevalence, etiology and prevention. Int J Urol. 2009; 16(1):49-57.
Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: Systematic review and meta-analysis. Epidemiol. 2005; 16(2):216-9.
Matalon S, Schechtman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: A meta-analysis of 1255 exposures. Reprod Toxicol. 2002; 16(1):9-17.
Heseker H. Folic acid and other potential measures in the prevention of neural tube defects. Ann Nutr Metab. 2011; 59(1):41-5.
Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. Jama. 1991; 266:1190-1.
Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. MMWR Morb Mortal Wkly Rep. 1991; 40:513-6.
Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet. 2002; 360(9350):2047-8.
Brasil. Ministério da Saúde. Agência Ncional de Vigilência Sanitária. Consulta Pública nº 51, de 10 de junho de 2002. Diário Oficial da União. 2002 12 jun; Seção 1.
Nascimento LFC. Prevalência de defeitos de fechamento de tubo neural no Vale do Paraíba, São Paulo. Rev Paul Pediatr. 2008; 26(4):372-7.
Breimer LH, Nilsson TK. Has folate a role in the developing nervous system after birth and not just during embryogenesis and gestation? Scand J Clin Lab Invest. 2012; 72(3):185-91.
Nakahara T, Uozumi T, Monden S, Muttaqin Z, Kurisu K, Arita K, et al. Prenatal diagnosis of open spina bifida by MRI and ultrasonography. Brain Dev. 1993; 15(1):75-8.
Worley G, Rosenfeld LR, Lipscomb J. Financial counseling for families of children with chronic disabilities. Dev Med Child Neurol. 1999; 33(8):679-89.
